Cargando…

Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus

Omeprazole is extensively used to manage gastroesophageal reflux disease (GERD). It is primarily metabolized by CYP2C19. The CYP2C19*17 (rs12248560) allele and the recently described CYP2C:TG haplotype (rs11188059 and rs2860840) are associated with increased enzymatic activity, and may reduce omepra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kee, Ping Siu, Maggo, Simran D. S., Kennedy, Martin A., Barclay, Murray L., Miller, Allison L., Lehnert, Klaus, Curtis, Maurice A., Faull, Richard L. M., Parker, Remai, Chin, Paul K. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160307/ https://www.ncbi.nlm.nih.gov/pubmed/35664313 http://dx.doi.org/10.3389/fgene.2022.869160

Ejemplares similares

The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses
por: Kee, Ping Siu, et al.
Publicado: (2023)

Buccal Buspirone as add–on Therapy to Omeprazole Versus Omeprazole in Treatment of Gastroesophageal Reflux Diseases (GERD)
por: Abdi, Saeed, et al.
Publicado: (2020)

Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease
por: Famouri, Fatemeh, et al.
Publicado: (2020)

Prevalence of Gastroesophageal Reflux in Cats During Anesthesia and Effect of Omeprazole on Gastric pH
por: Garcia, R.S., et al.
Publicado: (2017)

Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial
por: Bestebreurtje, Petra, et al.
Publicado: (2020)

Effect of a Combination of Omeprazole Plus Sustained Release Baclofen Versus Omeprazole Alone on Symptoms of Patients with Gastroesophageal Reflux Disease (GERD)
por: Abbasinazari, Mohammad, et al.
Publicado: (2014)

Comparing the Effect of Psyllium Seed on Gastroesophageal Reflux Disease With Oral Omeprazole in Patients With Functional Constipation
por: Hosseini, Mousalreza, et al.
Publicado: (2018)

Esophageal Acidification During Nocturnal Acid-breakthrough with Ilaprazole Versus Omeprazole in Gastroesophageal Reflux Disease
por: Karyampudi, Arun, et al.
Publicado: (2017)

Common CYP2D6, CYP2C9, and CYP2C19 Gene Variants, Health Anxiety, and Neuroticism Are Not Associated With Self-Reported Antidepressant Side Effects
por: Maggo, Simran, et al.
Publicado: (2019)

RNA Quality in Post-mortem Human Brain Tissue Is Affected by Alzheimer’s Disease
por: Highet, Blake, et al.
Publicado: (2021)

Gaviscon(® )vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial
por: Pouchain, Denis, et al.
Publicado: (2012)

Delayed-release oral suspension of omeprazole for the treatment of erosive esophagitis and gastroesophageal reflux disease in pediatric patients: a review
por: Monzani, Alice, et al.
Publicado: (2010)

Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoples
por: Hitchman, Leonie M., et al.
Publicado: (2022)

Omeprazole-Domperidone Fixed Dose Combination vs Omeprazole Monotherapy: A Phase 4, Open-Label, Comparative, Parallel Randomized Controlled Study in Mild to Moderate Gastroesophageal Reflux Disease
por: Marakhouski, KY, et al.
Publicado: (2017)

Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-Analysis
por: Xia, X. M., et al.
Publicado: (2013)

Validation of the Korean Version of the Gastroesophageal Reflux Disease Questionnaire for the Diagnosis of Gastroesophageal Reflux Disease
por: Gong, Eun Jeong, et al.
Publicado: (2019)

Obesity and gastroesophageal reflux disease and gastroesophageal reflux symptoms in children
por: Malaty, Hoda M, et al.
Publicado: (2009)

Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial
por: Sirinawasatien, Apichet, et al.
Publicado: (2019)

INFLUENCE OF EXERCISE TESTING IN GASTROESOPHAGEAL REFLUX IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE
por: MENDES-FILHO, Antonio Moreira, et al.
Publicado: (2014)

Pharmacogenetics of Statin-Induced Myotoxicity
por: Kee, Ping Siu, et al.
Publicado: (2020)

Gastroesophageal Reflux Disease
por: Kulkarni, Gaurav V., et al.
Publicado: (2013)

Gastroesophageal reflux in lockdown
por: Al-Momani, Hafez, et al.
Publicado: (2023)

Polymorphisms of the BARX1 and ADAMTS17 Locus Genes in Individuals With Gastroesophageal Reflux Disease
por: Argyrou, Alexandra, et al.
Publicado: (2019)

Gastroesophageal reflux disease in COPD: links and risks
por: Lee, Annemarie L, et al.
Publicado: (2015)

The Three Ps: Psychiatry, Pharmacy, and Pharmacogenomics, a Brief Report From New Zealand
por: Maggo, Simran D.S., et al.
Publicado: (2019)

A Randomized, Double Blinded, Clinical Trial to Assess the Efficacy and Cost Effectiveness of Omeprazole Compared to Rabeprazole in the Maintenance Therapy of Patients With Gastroesophageal Reflux Disease
por: Park, Jung Ho, et al.
Publicado: (2013)

Silent Gastroesophageal Reflux Disease
por: Lu, Ching-Liang
Publicado: (2012)

Refractory gastroesophageal reflux disease
por: Subramanian, Charumathi Raghu, et al.
Publicado: (2015)

Schizophrenia and gastroesophageal reflux symptoms
por: Kasap, Elmas, et al.
Publicado: (2015)

Gastroesophageal Reflux in Children with Asthma
por: Lupu, Vasile Valeriu, et al.
Publicado: (2022)

Gastroesophageal reflux in Bronchiectasis and the effect of anti-reflux treatment
por: Hu, Zhi-Wei, et al.
Publicado: (2013)

Endoscopic anti-reflux therapy for gastroesophageal reflux disease
por: Rodríguez de Santiago, Enrique, et al.
Publicado: (2021)

Salivary microbiome with gastroesophageal reflux disease and treatment
por: Kawar, Nadia, et al.
Publicado: (2021)

Impact of New Genomic Technologies on Understanding Adverse Drug Reactions
por: Maggo, Simran D. S., et al.
Publicado: (2015)

Erratum to: Impact of New Genomic Technologies on Understanding Adverse Drug Reactions
por: Maggo, Simran D. S., et al.
Publicado: (2016)

Statins and gastroesophageal reflux disease: A meta-analysis
por: Wijarnpreecha, K, et al.
Publicado: (2019)

Impact of self-reported Gastroesophageal reflux disease in subjects from COPDGene cohort
por: Martinez, Carlos H, et al.
Publicado: (2014)

Relevance of Position and Movement of the Gastroesophageal Junction in Gastroesophageal Reflux Disease
por: Lee, Yeong Yeh
Publicado: (2013)

The knife or the pill in the long-term treatment of gastroesophageal reflux disease?
por: Lundell, L. R.
Publicado: (1994)

Omeprazole and adenocarcinoma in the stomach of rats submitted to duodenogastric reflux. Is there a protective effect?
por: Monteiro, Rosângela Lucinda Rocha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0ebad4n5qhp4ge08fpnb2e131e